Main contents starts here

Overview

Takeda is a research-based global pharmaceutical company. As the largest pharmaceutical company in Japan and one of the global leaders of the industry. Setting our management philosophy, " Takeda-ism " as the basis of business, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products.
Takeda is enhancing its R&D pipeline by concentrating its management resources.
Takeda's in-house ethical drugs are marketed in around 90 countries worldwide and are recognized as the brand in major countries worldwide.

General Information

(As of March 31, 2008)
Company Name	Takeda Pharmaceutical Company Limited
Headquarters Head Office	1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645 TEL: +81 6 6204-2111 FAX: +81 6 6204-2880
Tokyo Head Office	12-10, Nihonbashi 2-chome, Chuo-ku, Tokyo 103-8668 TEL: +81 3 3278-2111 FAX: +81 3 3278-2000
Founded	June 12, 1781
Incorporated	January 29, 1925
President	Yasuchika Hasegawa
Paid-In Capital	¥63.5 billion
Number of Employees	6,115 (parent), 15,717 (consolidated)
Number of Shareholders	149,478
Scope of Business	Manufacturing, marketing and import / export of pharmaceutical drugs, etc.
R&D Facilities	Osaka, Tsukuba (Japan), Palo Alto, San Diego, San Francisco, Deerfield（U.S.）, London, Cambridge（U.K.）, Singapore
Production Facilities	Osaka, Hikari, Italy, Ireland, China, Indonesia
Overseas Subsidiaries and affiliates	U.S., U.K., France, Italy, Germany, Austria, Switzerland, Ireland, Netherlands, China, Taiwan, Philippines, Thailand, Indonesia, Singapore

Financial Highlights

	FY 2007 (April 2007 - March 2008)	FY 2006 (April 2006 - March 2007)
Net Sales	¥1,375 billion (US$13,748 million)	¥1,305 billion (US$11,061 million)
Net Income	¥355.5 billion (US$3,555 million)	¥335.8 billion (US$2,846 million)
R&D Investment	¥275.8billion (US$2,758 million)	¥193.3billion (US$1,638 million)
Earnings Per Share	¥418.97 (US4.19)	¥386.00 (US3.27)
Dividends Per Share	¥168.00 (US$1.68)	¥128.00 (US$1.08)
Consolidated Subsidiaries	47 companies	46 companies
Affiliated Companies Accounted for by the Equity Method	17 companies	21 companies

[*]Note: The U.S. dollar amounts represent translations of Japanese yen, for convenience only, at the rate of ¥100=US$1 for FY 2007 and ¥118=US$1 for FY 2006.